Welcure Drugs & Pharmaceuticals Ltd Q4 FY2024-2025 Results: Summary

Revenue
₹23.12Cr
Net Profits
₹2.54Cr
Net Profit Margins
10.99%
Highlights
Revenue:

Welcure Drugs & Pharmaceuticals Ltd’s revenue jumped 38433.33% since last year same period to ₹23.12Cr in the Q4 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 2527.27% jump in its revenue since last 3-months.

Net Profits:

Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 12800% since last year same period to ₹2.54Cr in the Q4 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 6250% jump in its net profits since last 3-months.

Net Profit Margins:

Welcure Drugs & Pharmaceuticals Ltd’s net profit margin jumped 132.96% since last year same period to 10.99% in the Q4 2024-2025. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 141.7% jumped in its net profit margins since last 3-months.

FAQs

What was the revenue for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2024?

The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was ₹23.12Cr.

What was the net profit for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2024?

The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was ₹2.54Cr.

What was the net profit margin for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2024?

The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was 10.99%.

What was the revenue for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2023?

The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.06Cr.

What was the net profit for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2023?

The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.02Cr.

What was the net profit margin for Welcure Drugs & Pharmaceuticals Ltd in Q4 results 2023?

The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was -33.33%.